Caulophyllogenin is a partial PPARγ agonist (EC50 = 12.6 μM) derived from the stem bark of Kalopanax pictus (Araliaceae). Caulophyllogenin inhibits pro-inflammatory cytokine secretion and can be used in studies about the prevention and treatment of inflammatory diseases, type-2 diabetes, obesity and metabolic syndrome.

Baptifoline is an alkaloid isolated from Anagyris foetida with potential antibacterial activity.

Caulophine has the ability to protect cardiomyocytes from oxidative and ischemic injury through an antioxidative mechanism.